Work

Abstract PR019: Combining CBP/p300 and PARP inhibitors to enhance anti-tumor efficacy in lethal prostate cancer

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.prostateca26-pr019

Authors: Orly I. Richter, Sumaira Sardar, Xiaohu Zhang, Jessica D. Kindrick, Lakshmi Ravindranath, Cindy H. Chau, Craig J. Thomas, Christopher McNair, Xiaofeng A. Su, Adam Sharp, Johann de Bono, Kris Frese, William D. Figg, Karen Knudsen, Ayesha A. Shafi

Institutions: National Center for Advancing Translational Sciences, National Cancer Institute, Thomas Jefferson University, Sidney Kimmel Cancer Center, Institute of Cancer Research, CellCentric (United Kingdom), Parker Institute for Cancer Immunotherapy

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7124848672

Cites:

Cited by:

Related to: